Dihydroergotoxine Mesylate
Dihydroergotoxine Mesylate Brand names, Dihydroergotoxine Mesylate Analogs
- Alkergot
- Circanol
- Co-Dergocrine Mesylate
- Deapril-ST
- Dihydroergotoxin Mesilat
- Dihydroergotoxin Mesylate
- Dihydroergotoxin Methanesulfonate
- Dihydroergotoxine Mesilate
- Dihydroergotoxine Mesylate
- Dihydroergotoxine Methanesulfonate
- Dihydroergotoxine Methanesulphonate
- Ergoloid Mesylates [Usan]
- Gerimal
- Hydergin
- Hydergine
- Hydergine LC
- Hydrogenated Ergot Alkaloids
- Ischelium
- Redergin
- Trigot
Dihydroergotoxine Mesylate Brand Names Mixture
- No information avaliable
Dihydroergotoxine Mesylate Chemical_Formula
C33H45N5O5
Dihydroergotoxine Mesylate RX_link
No information avaliable
Dihydroergotoxine Mesylate fda sheet
Dihydroergotoxine Mesylate msds (material safety sheet)
Dihydroergotoxine Mesylate Synthesis Reference
No information avaliable
Dihydroergotoxine Mesylate Molecular Weight
591.741 g/mol
Dihydroergotoxine Mesylate Melting Point
No information avaliable
Dihydroergotoxine Mesylate H2O Solubility
No information avaliable
Dihydroergotoxine Mesylate State
Solid
Dihydroergotoxine Mesylate LogP
2.615
Dihydroergotoxine Mesylate Dosage Forms
Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet
Dihydroergotoxine Mesylate Indication
For use as an adjunct therapy for patients with dementia
Dihydroergotoxine Mesylate Pharmacology
Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.
Dihydroergotoxine Mesylate Absorption
Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.
Dihydroergotoxine Mesylate side effects and Toxicity
Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.
Dihydroergotoxine Mesylate Patient Information
No information avaliable
Dihydroergotoxine Mesylate Organisms Affected
Humans and other mammals
